炎症性肠病患者结肠镜检查肠道准备的研究进展

doi:10.3969/j.issn.1004-583X.2024.11.012

摘要/Abstract

摘要：

结肠镜检查是炎症性肠病患者疾病诊断、病情评估和结肠炎相关异型增生监测的重要手段。而充分的肠道准备是高质量肠镜诊疗的重要保证和前提。炎症性肠病患者肠镜检查负担较重,还有其疾病特异性的肠道准备特征。本文综述近年来关于炎症性肠病患者肠镜检查肠道准备的最新研究进展,旨在为进一步优化该类患者的肠道准备提供参考。

关键词: 炎性肠疾病, 结肠镜检查, 肠道准备, 聚乙二醇

中图分类号:

R574

徐英刚, 杜甑衎, 刘婷婷, 李家速. 炎症性肠病患者结肠镜检查肠道准备的研究进展[J]. 临床荟萃, 2024, 39(11): 1035-1039.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2024.11.012

https://huicui.hebmu.edu.cn/CN/Y2024/V39/I11/1035

参考文献 31

[1]	Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment[J]. World J Gastroenterol, 2018, 24(35):4014-4020.
[2]	Mohamed MFH, Marino D, Elfert K, et al. Dye chromoendoscopy outperforms high-definition white light endoscopy in dysplasia detection for patients with inflammatory bowel disease: An updated meta-analysis of randomized controlled trials[J]. Am J Gastroenterol, 2024, 119(4):719-726. doi: 10.14309/ajg.0000000000002595 pmid: 38038351
[3]	Coelho-Prabhu N, Lewis JD. Update on endoscopic dysplasia surveillance in inflammatory bowel disease[J]. Am J Gastroenterol, 2023, 118(10):1748-1755.
[4]	Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD[J]. Gastroenterology, 2021, 160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031 pmid: 33359090
[5]	Maida M, Morreale GC, Sferrazza S, et al. Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases[J]. Dig Liver Dis, 2021, 53(9):1171-1177.
[6]	Kumar A, Shenoy V, Buckley MC, et al. Endoscopic disease activity and biologic therapy are independent predictors of suboptimal bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy[J]. Dig Dis Sci, 2022, 67(10):4851-4865.
[7]	Dai C, Tian W, Huang YH, et al. Effectiveness of 4 L, 2 L, and 1 L PEG bowel preparation for colonoscopy in patients with ulcerative colitis: A retrospective study[J]. Rev Esp Enferm Dig, 2023.
[8]	Hassan C, East J, Radaelli F, et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Update 2019[J]. Endoscopy, 2019, 51(8):775-794.
[9]	Buisson A, Gonzalez F, Poullenot F, et al. Comparative acceptability and perceived clinical utility of monitoring tools: A nationwide survey of patients with inflammatory bowel disease[J]. Inflamm Bowel Dis, 2017, 23(8):1425-1433. doi: 10.1097/MIB.0000000000001140 pmid: 28570431
[10]	Te Groen M, Derks M, den Broeder N, et al. Quality of surveillance impacts the colitis-associated advanced neoplasia risk: A multicenter case-control study[J]. Clin Gastroenterol Hepatol, 2024, 22(2):357-367.
[11]	Wijnands AM, Te Groen M, Peters Y, et al. Patients prioritize a low-volume bowel preparation in colitis-associated colorectal cancer surveillance: A discrete choice experiment[J]. Inflamm Bowel Dis, 2022, 28(7):1053-1060.
[12]	Belvis Jiménez M, Hergueta-Delgado P, Gómez Rodríguez BJ, et al. Index of the mayo endoscopy and ulcerative colitis endoscopy index of severity: Are they equally valid?[J] Rev Esp Enferm Dig, 2020, 112(11):821-825. doi: 10.17235/reed.2020.6832/2019 pmid: 33054301
[13]	Elford AT, Hirsch R, McKay OM, et al. Identifying the real-world challenges of dysplasia surveillance in inflammatory bowel disease: A retrospective cohort study in a tertiary health network[J]. Intern Med J, 2024, 54(1):96-103.
[14]	Santi G, Michetti P, Froehlich F, et al. Adherence to recommendations and quality of endoscopic colorectal cancer surveillance in long-standing ulcerative colitis[J]. Inflamm Bowel Dis, 2021, 6(1):25-31.
[15]	中国医师协会内镜医师分会消化内镜专业委员会, 中国抗癌协会肿瘤内镜学专业委员会. 中国消化内镜诊疗相关肠道准备指南(2019, 上海)[J]. 中华内科杂志, 2019, 58(7):485-495.
[16]	Hashimoto Y, Kuribayashi S, Itoi Y, et al. Safety of full bowel preparation and colonoscopy in elderly patients with ulcerative colitis: A real-world multicenter retrospective cohort study[J]. DEN Open, 2024, 4(1):e275.
[17]	Burnett-Hartman AN, Hua X, Rue TC, et al. Risk interval analysis of emergency room visits following colonoscopy in patients with inflammatory bowel disease[J]. PLoS One, 2019, 14(1):e0210262.
[18]	Rejchrt S, Bures J, Siroký M, et al. A prospective, observational study of colonic mucosal abnormalities associated with orally administered sodium phosphate for colon cleansing before colonoscopy[J]. Gastrointest Endosc, 2004, 59(6):651-654. pmid: 15114307
[19]	Restellini S, Kherad O, Bessissow T, et al. Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease[J]. World J Gastroenterol, 2017, 23(32):5994-6002.
[20]	Bezzio C, Schettino M, Manes G, et al. Tolerability of bowel preparation and colonoscopy in IBD patients: results from a prospective, single-center, case-control study[J]. Crohns Colitis 360, 2020, 2(4):otaa077.
[21]	Neri B, Scarozza P, Giannarelli D, et al. Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases[J]. Eur J Gastroenterol Hepatol, 2021, 33(7):977-982.
[22]	Kim KO, Kim EY, Lee YJ, et al. Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study[J]. J Crohns Colitis, 2022, 16(11):1706-1713.
[23]	Lee JM, Lee KM, Kang HS, et al. Oral sulfate solution is as effective as polyethylene glycol with ascorbic acid in a split method for bowel preparation in patients with inactive ulcerative colitis: A randomized, multicenter, and single-blind clinical trial[J]. Gut Liver, 2023, 17(4):591-599. doi: 10.5009/gnl220202 pmid: 36588527
[24]	Briot C, Faure P, Parmentier AL, et al. Efficacy, tolerability, and safety of low-volume bowel preparations for patients with inflammatory bowel diseases: The French multicentre CLEAN study[J]. J Crohns Colitis, 2019, 13(9):1121-1130. doi: 10.1093/ecco-jcc/jjz040 pmid: 30785181
[25]	Rueda García JL, Suárez Ferrer C, Martín-Arranz E, et al. Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with inflammatory bowel disease: the EII-PREP trial[J]. Scand J Gastroenterol, 2023, 58(6):656-663.
[26]	Mohsen W, Williams AJ, Wark G, et al. Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?[J] World J Gastroenterol, 2021, 27(11):1090-1100.
[27]	Bacsur P, Rutka M, Asbóth A, et al. Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls[J]. Therap Adv Gastroenterol, 2023, 16:17562848231174298.
[28]	Powles STR, Gallagher KI, Chong LWL, et al. Effects of bowel preparation on intestinal bacterial associated urine and faecal metabolites and the associated faecal microbiome[J]. BMC Gastroenterol, 2022, 22(1):240. doi: 10.1186/s12876-022-02301-1 pmid: 35562657
[29]	Gajera A, South C, Cronley KM, et al. High-volume colonic lavage is a safe and preferred colonoscopy preparation for patients with inflammatory bowel disease[J]. Crohns Colitis 360, 2022, 4(3):otac024.
[30]	Megna B, Weiss J, Ley D, et al. Clear liquid diet before bowel preparation predicts successful chromoendoscopy in patients with inflammatory bowel disease[J]. Gastrointest Endosc, 2019, 89(2):373-379.
[31]	Maratt JK, Siegel CA, Barkun AN, et al. An expert consensus to standardize assessment of bowel cleansing for clinical trials of bowel preparations for Crohn's disease[J]. Dig Dis Sci, 2023, 68(5):1718-1727.

炎症性肠病患者结肠镜检查肠道准备的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 31

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈晓天, 霍丽娟. 血清总胆红素水平在炎症性肠病中临床意义的meta分析[J]. 临床荟萃, 2023, 38(8): 677-685.
[2]	杨旻星, 庄姝洁, 韩文娟, 张海云, 叶赟. 低纤维肠内营养素对糖尿病患者肠道准备质量、血糖及舒适度的影响[J]. 临床荟萃, 2022, 37(4): 349-353.
[3]	佟印妮1，郑吉敏2. 功能性便秘诊断技术的进展[J]. 临床荟萃, 2020, 35(6): 573-576.
[4]	韩旭，郭亚慧，时晓冬，张晓岚. 2019版《中国消化内镜诊疗相关肠道准备指南》解读[J]. 临床荟萃, 2020, 35(1): 72-75.
[5]	刘丹，姚萍. 饮食对结肠镜检查前肠道准备影响的研究现状[J]. 临床荟萃, 2019, 34(1): 85-87.
[6]	葛超毅, 王化虹. 炎症性肠病营养支持治疗进展[J]. 临床荟萃, 2018, 33(8): 650-655,660.
[7]	宋岩1，杨虎2，姜葵1，王邦茂1. 沙利度胺及其类似物治疗炎症性肠病的系统性回顾[J]. 临床荟萃, 2018, 33(5): 434-439.
[8]	李玥，钱家鸣. 炎症性肠病合并艰难梭菌感染的研究进展[J]. 临床荟萃, 2018, 33(5): 394-397.
[9]	吴德明，周月红，祁文，段延旺. 哨兵息肉的临床特征[J]. 临床荟萃, 2016, 31(9): 1027-1029.
[10]	李玥，钱家鸣. 免疫抑制剂在炎症性肠病治疗中的应用进展[J]. 临床荟萃, 2016, 31(8): 824-827.
[11]	郭金波，张晓岚. 5-氨基水杨酸在炎症性肠病中的合理应用[J]. 临床荟萃, 2016, 31(8): 820-823.
[12]	雷蕾1，2，张晓岚1，尹凤荣1. 机会性感染与炎症性肠病[J]. 临床荟萃, 2016, 31(8): 865-868.
[13]	牛巍巍，赵丹丹，霍晓霞. 幽门螺杆菌与炎症性肠病[J]. 临床荟萃, 2016, 31(8): 861-964.
[14]	迟雁. 肠道微生态与炎症性肠病[J]. 临床荟萃, 2016, 31(8): 857-860.
[15]	王冬，张晓岚. 内镜在炎症性肠病中的作用[J]. 临床荟萃, 2016, 31(8): 852-856.